Endothelial nitric oxide-mediated Nrf2 activation as a novel mechanism for vascular and neuroprotection by erythropoietin in experimental subarachnoid hemorrhage.
Genc
Sermin
S
Egrilmez
Mehtap Yuksel
MY
Genc
Kursad
K
D000818:Animals; D004195:Disease Models, Animal; D004730:Endothelium, Vascular / Q000378:metabolism; D004921:Erythropoietin / Q000627:therapeutic use*; D005786:Gene Expression Regulation; D051379:Mice; D018345:Mice, Knockout; D051267:NF-E2-Related Factor 2 / Q000235:genetics / Q000378:metabolism*; D018696:Neuroprotective Agents / Q000627:therapeutic use*; D009569:Nitric Oxide / Q000378:metabolism*; D013345:Subarachnoid Hemorrhage / Q000188:drug therapy* / Q000235:genetics
D051267:NF-E2-Related Factor 2; C495635:NFE2L2 protein, human; D018696:Neuroprotective Agents; D004921:Erythropoietin; D009569:Nitric Oxide